Summary:
Sleep Specialists LLC announced that the FDA-cleared Zzoma positional sleeper for positional obstructive sleep apnea (OSA) has been added to First Nation Group’s Federal Supply Schedule (FSS), making it more accessible for US Department of Veterans Affairs sleep centers. The device, which meets Trade Agreement Act requirements, is designed to promote side sleeping as a treatment for mild to moderate positional OSA and snoring. The listing on the FSS is expected to streamline procurement and expand access to an alternative therapy for veterans.
Key Takeaways:
- Zzoma Positional Sleeper Added to Federal Supply Schedule – VA sleep centers can now procure the FDA-cleared device through First Nation Group’s FSS.
- TAA-Compliant Device Designed for Positional OSA – The Zzoma sleeper promotes side sleeping to help maintain an open airway for veterans with mild to moderate positional OSA.
- Listing Expected to Improve Access and Procurement – The inclusion of Zzoma on the FSS may simplify ordering processes for VA clinicians and expand treatment options for veterans.
Sleep Specialists LLC, operating as 2Z Medical, manufacturer of the US Food and Drug Administration-cleared Zzoma positional sleeper for the treatment of mild to moderate positional obstructive sleep apnea (OSA), announced that Zzoma has been added to First Nation Group’s Federal Supply Schedule (FSS). This inclusion ensures easier access for US Department of Veterans Affairs (VA) sleep centers and veterans.
The Zzoma positional sleeper, manufactured to meet the US Trade Agreement Act (TAA) requirements, provides government healthcare providers with a clinically proven treatment for veterans with mild to moderate OSA and snoring. This TAA-compliant product, designed by physicians, promotes side sleeping, allowing Zzoma to help maintain an open airway and improve sleep quality.
“The addition of Zzoma to First Nation Group’s FSS contract is an important milestone, demonstrating the growing recognition and trust that sleep specialists within the VA have in Zzoma as an effective and comfortable treatment option for their patients experiencing mild to moderate positional OSA,” says Michael J Markus, PhD, executive director at Sleep Specialists LLC, in a release. “We are thrilled with the high adoption rate among VA physicians as an alternative solution. With the TAA-compliant Zzoma now available on FSS, procurement will be streamlined, significantly improving the quality of care for Veterans.”
Through this partnership, 2Z Medical and First Nation Group—a distributor of medical-surgical equipment and supplies, generic pharmaceutical products, and remote setup solutions exclusively serving the US Federal government—will continue to collaborate to ensure clinicians can access Zzoma as a first-line alternative therapy for veterans.
“We value the strong partnership with 2Z Medical in delivering outstanding solutions for sleep patients. We remain committed to being a reliable resource for our Government customers, ensuring they have access to innovative solutions to support Veterans,” says Glenn Munroe, executive vice president of operations, in a release.
According to the company, more than 1,900 sleep specialists across the United States are now prescribing Zzoma to their patients, and over 1,400 sleep clinics are actively offering it as an alternative to traditional CPAP therapy.
Photo caption: Zzoma
File photo
